ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,751.07
      0.90%
      US Tech 100
      19,476.00
      1.10%
      Dow Jones
      42,352.75
      0.81%
      Brent Oil
      77.97
      0.00%
      Bitcoin
      61,798.25
      -0.45%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX

      6. Synthetic Biologics Inc (SYN) Quote

      Synthetic Biologics Inc

      Synthetic Biologics Inc (SYN)

      Synergia Energy Ltd
      Synergia Energy Ltd
      1.02
      0.00
      (0.00%)
      Closed October 05 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.02
      Bid
      -
      Ask
      -
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      17.384M
      Previous Close
      1.02
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      17,043,000
      Dividend Yield
      -
      PE Ratio
      -1.53
      Earnings Per Share (EPS)
      -1.08
      Revenue
      -
      Net Profit
      -18.35M

      About Synthetic Biologics Inc

      Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbio... Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery stage biotherapeutics for the treatment of phenylketonuria. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Business Services
      Website
      www.syntheticbiologics.com
      Headquarters
      Rockville, Maryland, USA
      Founded
      1993

      Ask ADVFN Intelligence (AI)

      SYN Latest News

      More News

      Synthetic Biologics to Present at 2022 BIO CEO & Investor Conference

      Synthetic Biologics to Present at 2022 BIO CEO & Investor Conference PR Newswire ROCKVILLE, Md., Feb. 9, 2022 ROCKVILLE, Md., Feb. 9, 2022 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE...

      February 09 2022
      PR Newswire (US)

      Synthetic Biologics Announces VCN Biosciences' VCN-01 Receives Orphan Drug Designation for Retinoblastoma from the U.S. FDA

      Synthetic Biologics Announces VCN Biosciences' VCN-01 Receives Orphan Drug Designation for Retinoblastoma from the U.S. FDA Follows recent announcement of planned acquisition of VCN Biosciences...

      February 08 2022
      PR Newswire (US)

      Synthetic Biologics to Present at the B. Riley Securities Oncology Conference on January 28, 2022

      Synthetic Biologics to Present at the B. Riley Securities Oncology Conference on January 28, 2022 PR Newswire ROCKVILLE, Md., Jan. 26, 2022 ROCKVILLE, Md., Jan. 26, 2022 /PRNewswire/ -- Synthetic...

      January 26 2022
      PR Newswire (US)

      Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid Tumors

      Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid Tumors Lead drug candidate...

      December 14 2021
      PR Newswire (US)

      Synthetic Biologics Reports Third Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET

      Synthetic Biologics Reports Third Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET Initiated a Phase 1 Multiple Ascending Dose Clinical...

      November 03 2021
      PR Newswire (US)

      Synthetic Biologics to Report 2021 Third Quarter Operational Highlights and Financial Results on November 3, 2021

      Synthetic Biologics to Report 2021 Third Quarter Operational Highlights and Financial Results on November 3, 2021 -- Conference Call Scheduled for Wednesday, November 3, 2021 at 4:30 p.m. ET...

      October 26 2021
      PR Newswire (US)

      Synthetic Biologics Announces Initiation of a Phase 1 Multiple-Ascending Dose Clinical Trial for SYN-020 Intestinal Alkaline Phosphatase

      Synthetic Biologics Announces Initiation of a Phase 1 Multiple-Ascending Dose Clinical Trial for SYN-020 Intestinal Alkaline Phosphatase Topline Data Readout Expected in Q2 2022 Phase 1 Clinical...

      October 21 2021
      PR Newswire (US)

      Synthetic Biologics Announces Second Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

      Synthetic Biologics Announces Second Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum The Company Encourages All Shareholders of Record Who Have Not Yet Voted to Do So by...

      October 06 2021
      PR Newswire (US)

      Synthetic Biologics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

      Synthetic Biologics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum PR Newswire ROCKVILLE, Md., Sept. 21, 2021 ROCKVILLE, Md., Sept. 21, 2021 /PRNewswire/...

      September 21 2021
      PR Newswire (US)

      Synthetic Biologics Reports Second Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET

      Synthetic Biologics Reports Second Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET Phase 1 Single-Ascending Dose Clinical Trial of...

      August 05 2021
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BQBoqii Holding Limited
      $ 0.6197
      (34.54%)
      		3.22M
      LSFLaird Superfood Inc
      $ 6.29
      (20.73%)
      		364.09k
      BKTIBK Technologies Corporation
      $ 23.87
      (17.47%)
      		61.2k
      VNRXVolitionRX Limited
      $ 0.883
      (16.21%)
      		304.93k
      MSTUT Rex 2X Long MSTR Daily Target ETF
      $ 43.38
      (15.53%)
      		3.41M
      SEG.RTSeaport Entertainment Group Inc
      $ 1.64
      (-30.21%)
      		223.4k
      IBOImpact Biomedical Inc
      $ 1.2701
      (-23.02%)
      		133.7k
      UAVSAgEagle Aerial Systems Inc
      $ 0.0962
      (-20.82%)
      		8.14M
      PWPower REIT
      $ 1.45
      (-19.44%)
      		13.66M
      EONREON Resources Inc
      $ 1.45
      (-18.54%)
      		2.12M
      SOXLDirexion Daily Semiconductor Bull 3X Shares
      $ 36.68
      (4.17%)
      		101.13M
      TELLTellurian Inc
      $ 0.9776
      (0.77%)
      		95.87M
      FXIiShares China Large Cap
      $ 35.71
      (3.51%)
      		91.88M
      YANGDirexion Daily FTSE China Bear 3X Shares New
      $ 2.75
      (-10.13%)
      		80.65M
      SOXSDirexion Daily Semiconductor Bear 3X Shares New
      $ 20.02
      (-4.07%)
      		65.79M

      Discussion

      View Full Feed
      RiskyRascal RiskyRascal 3 minutes ago
      Yes watch the presentation from Bonnie. She says they are waiting for Broadcom to ship out their switches.
      SEV
      crazy horse 0 crazy horse 0 4 minutes ago
      Follow this site for weather


      Mike's Weather Page
      https://www.facebook.com/mikesweatherpage
      nyt nyt 4 minutes ago
      They're just pouring in, eh? Hope you can keep up with the count....

      Just like no results of the nodal testing have ever been produced and no evidence that USPTO requested working models of the patents. And. ;oooo{88
      VPLM
      Hopeforthefuture3 Hopeforthefuture3 4 minutes ago
      Horse, I hope they write a book when all is done. I would like to hear the real detail as to what has gone on for the last decade. Title either the great success or the great demise
      Either way would be good to get the full story
      NWBO
      WooptdooU WooptdooU 4 minutes ago
      The lwlg GRIFT situation and liability MAY HAVE influenced the CPA firm to duck and cover...this was a scenario of CASH TAKEN (with approval from the cowardly UNADMIRAL ship jumper...head of the compensation committee and then, yes, HE QUIT).

      Oh well, the GRIFTING lebby's proly love t
      LWLG
      peafunke peafunke 5 minutes ago
      I denied ‘what’s Mr Conspiracy ?
      TPTW
      Info3 Info3 7 minutes ago
      Always a colorful board here ! Interesting reading I must say
      BMXI
      doc2016 doc2016 7 minutes ago
      call winning:dod working with openai on military chatgpt. initially for suicide prevention.
      Royal Dude Royal Dude 7 minutes ago
      This is very important and when you research this for Series A and has a limit if 130B pg 20. Nov 1st is our first interest paymenr for calander year December 31st. I believe series A is for U's and P's will take case of themself. Just from a believer of Justice :) Royal

      Here is an ex
      COOP
      satter satter 8 minutes ago
      Thank you but I read the security agreements.

      Foxo is a guarantor on the note, not the only one. If the note defaults, Rnva will have enforceable options for the guarantor on its collateral. This is pretty standard for a secured loan.

      But Rnva does not gain ownership, n
      RNVA
      asp42001 asp42001 9 minutes ago
      Varity Of Needs For Flood & Other Victims

      (USIO Website) In-Part:

      Usio Akimbo Prepaid card solution empowers businesses, nonprofits & government entities to effortlessly create & manage disbursements for a variety of needs....

      P2P helping-hand card money
      USIO
      investingnotgambling investingnotgambling 10 minutes ago
      Belisarian has 3 others granted…BUSC ENCC and KNBA. Maybe Cohen keeps working with Belisarian on all of those. Keep those on your radar. I hold no shares in any but may keep tabs and on them. ZHUD by far is my biggest holding right now - looking forward to great days/weeks/months/years ahead.
      BUSC ENCC KNBA
      StayHumble StayHumble 10 minutes ago
      FullYear Sales $55M+Up 90%🟩Gross Profit $20M+Up 99%🟩
      https://www.healthiercmc.com/news/240327-hcmc-q4-2023-results
      HCWC
      mick mick 11 minutes ago
      ISRAEL SHOULD GO IRAN ALL OUT
      Mozy429 Mozy429 12 minutes ago
      Thank you. I appreciate your perspective. It’s definitely something I’m struggling with. I was greedy last time and lost out on probably $100k. Now, I’m in a much better place where my cost is less than 9 cents since I’ve been averaging down. I didn’t sell then…now, my fear is I don’t want to sell e
      ELTP
      Hopeforthefuture3 Hopeforthefuture3 12 minutes ago
      Al4door, good luck to you I hope you end up doing very well. I would encourage you to consider diversification in your stocks or at least add mutual funds. Hope you are not "all in" on nwbo as this is your only stock- just in case something unexpected happens. Good you have patience, they have just
      NWBO
      jimr1717 jimr1717 12 minutes ago
      IFUS DD Updated 🏆️ >>, Marc Walther was found liable in a securities fraud lawsuit...

      Complaint:
      https://drive.google.com/file/d/1Wpk0lRCJaTOI3dmR_BeSNw6eWtnTt71s/view

      Judgement: $397,744.50
      https://drive.google.com/file/d/1nZjmmsmCwJlFwm9TR6NvokHH
      HGYN HYGN IFUS
      StayHumble StayHumble 12 minutes ago
      🟩Yes! CE0KevinLamb🟩T0P10 Healthcare innovators🟩F0rbes Huzzah! $UBQU
      https://x.com/CorporateUbqu/status/1802724359762506049https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
      UBQU
      mick mick 13 minutes ago
      WATCHING ALL DAY REVIEW ON AMVO NETWORK FOR BUTLER . PA
      dstock07734 dstock07734 14 minutes ago
      Absolutely!

      Researchers from NWBO and UCLA can play dendritic cells like great masters. They can let dendritic cells present various antigens to immune systems for both humans and mammals. Dendritic cells trained by NWBO technology can present immune system with antigens that cause he
      NWBO
      LA4321 LA4321 14 minutes ago
      this thing should be @ .05 .....now........minimum.....
      DUTV
      jimr1717 jimr1717 14 minutes ago
      Shares Revoked soon. Shrimpscam
      SHMP
      choctaw choctaw 14 minutes ago
      DITTO !!!
      MONI
      Monksdream Monksdream 14 minutes ago
      HIMS YTD
      https://investorshub.advfn.com/uimage/uploads/2024/10/5/tnmtmIMG_2259.gif
      HIMS
      Horseb4CarT Horseb4CarT 15 minutes ago
      This time will be different:-)
      NWBO

      Your Recent History

      AMEX
      SYN
      Synthetic Biologics
      Delayed Upgrade Clock